Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy

• Auteurs principaux: Jun-Seop Kim (Auteur), Jong-Hak Lee (Auteur), Owen Kwon (Auteur), Jang-Hee Cho (Auteur), Ji-Young Choi (Auteur), Sun-Hee Park (Auteur), Chan-Duck Kim (Auteur), Yong-Jin Kim (Auteur), Yong-Lim Kim (Auteur)
• Format: Livre
• Publié: The Korean Society of Nephrology, 2017-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Administration of autologous mesenchymal stem cells (MSCs) has been shown to improve renal function and histological findings in acute kidney injury (AKI) models. However, its effects in chronic kidney disease (CKD) are unclear, particularly in the clinical setting. Here, we report our experience wi...